OPTN/SRTR 2011 Annual Data Report: Kidney

American Journal of Transplantation

Volumn 13, Issue SUPPL. 1, 2013, Pages 11-46

  Matas, A J ^a,b   Smith, J M ^a,c   Skeans, M A ^a   Lamba, K E ^a   Gustafsona, S K ^a   Samana, C J ^d,e   Stewart, D E ^d,e   Snyder, J J ^a,f   Israni, A K ^a,b,f   Kasiske, B L ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Organ Procurement and Transplantation Network   (United States)

^e UNITED NETWORK FOR ORGAN SHARING   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

End stage renal disease; Kidney transplant; Transplant outcomes; Transplant waiting list

Indexed keywords

BELATACEPT; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CADAVER DONOR; CANCER INCIDENCE; CAUSE OF DEATH; DESENSITIZATION; DRUG APPROVAL; DRUG USE; END STAGE RENAL DISEASE; EPSTEIN BARR VIRUS; ETHNIC DIFFERENCE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMODIALYSIS PATIENT; HLA MATCHING; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; MAINTENANCE THERAPY; MORTALITY; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; DONOR; UNITED STATES;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; TISSUE DONORS; UNITED STATES; WAITING LISTS;

EID: 84877252421     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12019     Document Type: Article

References (0)